Faculty

Anna Wald

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Laboratory Medicine and Pathology
Division Head, Allergy & Infectious Diseases, Medicine - Allergy and Infectious Dis.

206-520-4340

Education

MD Medicine, Mt Sinai School of Medicine, 1985
MPH Epidemiology, University of Washington, 1994
BA Comparative Religion, Wesleyan University, 1979

Contact

206-520-4340

University of Washington
Box 359928
325 9th Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Wald's current research centers on the epidemiology and natural history of chronic viral infections in immunocompetent and immunocompromised hosts. She is also working on clinical trials of antiviral therapeutics and prophylactic and therapeutic vaccines for viral pathogens. Other ongoing studies address the interaction between sexually transmitted infections and microbiome.

Recent Publications (PubMed)

Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.
(2025 Jun 26)
J Infect 91(2): 106543
Kalkeri R, Zhu M, Cloney-Clark S, Parekh A, Gorinson D, Cai Z, Cai MR, Mahato S, Chau G, Babu TM, Wald A, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Dunkle LM, Chung AW, Plested JS
Immunization with full-length TprC variants induces a broad response to surface-exposed epitopes of the Treponema pallidum repeat protein family and is partially protective in the rabbit model of syphilis.
(2025 Jun 25)
Vaccine 61(): 127406
Giacani L, Romeis E, Haynes A, Molini BJ, Tantalo LC, Xu LH, Trejos AT, Keane J, Mohamed Z, Armstrong TD, Wieland BA, Phung Q, Vyshenska D, Campbell VL, Godornes C, Koelle DM, Reid TB, Wang Y, Vorobieva AA, Wald A, Lieberman NAP, Greninger AL
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.
(2025 Jan 29)
Clin Infect Dis
Chemaly RF, Shafat T, Wald A, Kotton CN, Papanicolaou G, Yong MK, Miller V, Komatsu TE, Mullick C, Hodowanec AC, Westman G, Khawaja F, Birkmann A, Ljungman P
Herpes-Reply.
(2025 Jan 28)
JAMA 333(4): 351
Johnston C, Wald A
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents.
(2025 Jun 21)
bioRxiv
Ellison ST, Hayman I, Derr K, Derr P, Frebert S, Itkin Z, Shen M, Jones A, Olson W, Corey L, Wald A, Johnston C, Fong Y, Ferrer M, Zhu J
Show complete publication list